Literature DB >> 24035723

Characterization of tumorigenic cell lines from the recurrence and lymph node metastasis of a human salivary mucoepidermoid carcinoma.

Kristy A Warner1, April Adams, Lisiane Bernardi, Carolina Nor, Kelsey A Finkel, Zhaocheng Zhang, Scott A McLean, Joseph Helman, Gregory T Wolf, Vasu Divi, Lurdes Queimado, Frederic J Kaye, Rogerio M Castilho, Jacques E Nör.   

Abstract

UNLABELLED: The long-term outcome of patients with mucoepidermoid carcinoma is poor. Limited availability of cell lines and lack of xenograft models is considered a major barrier to improved mechanistic understanding of this disease and development of effective therapies.
OBJECTIVE: To generate and characterize human mucoepidermoid carcinoma cell lines and xenograft models suitable for mechanistic and translational studies.
METHODS: Five human mucoepidermoid carcinoma specimens were available for generation of cell lines. Cell line tumorigenic potential was assessed by transplantation and serial in vivo passaging in immunodeficient mice, and cell line authenticity verified by short tandem repeat (STR) profiling.
RESULTS: A unique pair of mucoepidermoid carcinoma cell lines was established from a local recurrence (UM-HMC-3A) and from the metastatic lymph node (UM-HMC-3B) of the same patient, 4 years after surgical removal of the primary tumor. These cell lines retained epithelial-like morphology through 100 passages in vitro, contain the Crtc1-Maml2 fusion oncogene (characteristic of mucoepidermoid carcinomas), and express the prototypic target of this fusion (NR4A2). Both cell lines generated xenograft tumors when transplanted into immunodeficient mice. Notably, the xenografts exhibited histological features and Periodic Acid Schiff (PAS) staining patterns that closely resembled those found in human tumors. STR profiling confirmed the origin and authenticity of these cell lines.
CONCLUSION: These data demonstrate the generation and characterization of a pair of tumorigenic salivary mucoepidermoid carcinoma cell lines representative of recurrence and lymph node metastasis. Such models are useful for mechanistic and translational studies that might contribute to the discovery of new therapies for mucoepidermoid carcinoma.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Crtc1–Maml2; Metastasis; Mouse models; Oral cancer; Salivary gland cancer; Tumor recurrence; Xenograft

Mesh:

Substances:

Year:  2013        PMID: 24035723      PMCID: PMC3821871          DOI: 10.1016/j.oraloncology.2013.08.004

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  27 in total

Review 1.  Emerging biology of malignant salivary gland tumors offers new insights into the classification and treatment of mucoepidermoid cancer.

Authors:  Frederic J Kaye
Journal:  Clin Cancer Res       Date:  2006-07-01       Impact factor: 12.531

2.  UT-MUC-1, a new mucoepidermoid carcinoma cell line, and its radiosensitivity.

Authors:  R Grénman; K Pekkola-Heino; H Joensuu; K Aitasalo; P Klemi; T Lakkala
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1992-05

3.  CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: implications for histogenesis and biologic behavior.

Authors:  Yamilet Tirado; Michelle D Williams; Ehab Y Hanna; Frederic J Kaye; John G Batsakis; Adel K El-Naggar
Journal:  Genes Chromosomes Cancer       Date:  2007-07       Impact factor: 5.006

4.  Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth.

Authors:  J E Nör; J Christensen; J Liu; M Peters; D J Mooney; R M Strieter; P J Polverini
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

5.  Sustained expression of Mect1-Maml2 is essential for tumor cell growth in salivary gland cancers carrying the t(11;19) translocation.

Authors:  T Komiya; Y Park; S Modi; A B Coxon; H Oh; F J Kaye
Journal:  Oncogene       Date:  2006-05-01       Impact factor: 9.867

Review 6.  Management of salivary gland tumors.

Authors:  Guy Andry; Marc Hamoir; Laura D Locati; Lisa Licitra; Johannes A Langendijk
Journal:  Expert Rev Anticancer Ther       Date:  2012-09       Impact factor: 4.512

7.  Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes.

Authors:  Amy Coxon; Ester Rozenblum; Yoon-Soo Park; Nina Joshi; Junji Tsurutani; Phillip A Dennis; Ilan R Kirsch; Frederic J Kaye
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

8.  t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway.

Authors:  Giovanni Tonon; Sanjay Modi; Lizi Wu; Akihito Kubo; Amy B Coxon; Takefumi Komiya; Kevin O'Neil; Kristen Stover; Adel El-Naggar; James D Griffin; Ilan R Kirsch; Frederic J Kaye
Journal:  Nat Genet       Date:  2003-01-21       Impact factor: 38.330

Review 9.  Salivary gland cancers: current treatments, molecular characteristics and new therapies.

Authors:  Sreenivasa R Chandana; Barbara A Conley
Journal:  Expert Rev Anticancer Ther       Date:  2008-04       Impact factor: 4.512

10.  Salivary mucoepidermoid carcinoma: a multi-institutional review of 76 patients.

Authors:  Shuting Bai; Rashna Clubwala; Esther Adler; Cathy Sarta; Bradley Schiff; Richard V Smith; Douglas R Gnepp; Margaret Brandwein-Gensler
Journal:  Head Neck Pathol       Date:  2012-10-19
View more
  30 in total

1.  Autophagic reliance promotes metabolic reprogramming in oncogenic KRAS-driven tumorigenesis.

Authors:  H Helen Lin; Yiyin Chung; Chun-Ting Cheng; Ching Ouyang; Yong Fu; Ching-Ying Kuo; Kevin K Chi; Maryam Sadeghi; Peiguo Chu; Hsing-Jien Kung; Chien-Feng Li; Kirsten H Limesand; David K Ann
Journal:  Autophagy       Date:  2018-08-21       Impact factor: 16.016

2.  UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell line.

Authors:  Kristy A Warner; Alexandra E Oklejas; Alexander T Pearson; Zhaocheng Zhang; Weishing Wu; Vasu Divi; Christie Rodriguez-Ramirez; Rogerio M Castilho; Peter J Polverini; Jacques E Nör
Journal:  Oral Oncol       Date:  2018-10-18       Impact factor: 5.337

3.  Cephaeline is an inductor of histone H3 acetylation and inhibitor of mucoepidermoid carcinoma cancer stem cells.

Authors:  Luan César Silva; Gabriell Bonifácio Borgato; Vivian Petersen Wagner; Manoela Domingues Martins; Guilherme Zweig Rocha; Márcio Ajudarte Lopes; Alan Roger Santos-Silva; Gilberto de Castro Júnior; Luiz Paulo Kowalski; Jacques E Nor; Cristiane H Squarize; Rogerio Moraes Castilho; Pablo Agustin Vargas
Journal:  J Oral Pathol Med       Date:  2021-10-27       Impact factor: 3.539

4.  Salivary Gland Cancer Patient-Derived Xenografts Enable Characterization of Cancer Stem Cells and New Gene Events Associated with Tumor Progression.

Authors:  Stephen B Keysar; Justin R Eagles; Bettina Miller; Brian C Jackson; Farshad N Chowdhury; Julie Reisinger; Tugs-Saikhan Chimed; Phuong N Le; John J Morton; Hilary L Somerset; Marileila Varella-Garcia; Aik-Choon Tan; John I Song; Daniel W Bowles; Mary E Reyland; Antonio Jimeno
Journal:  Clin Cancer Res       Date:  2018-03-19       Impact factor: 12.531

5.  Inhibition of Protein Phosphatase 2A Sensitizes Mucoepidermoid Carcinoma to Chemotherapy via the PI3K-AKT Pathway in Response to Insulin Stimulus.

Authors:  Limin Liu; Herui Wang; Jing Cui; Qi Zhang; Wei Zhang; Wanlin Xu; Hao Lu; Shengwen Liu; Shukun Shen; Francia Fang; Lei Li; Wenjun Yang; Zhengping Zhuang; Jiang Li
Journal:  Cell Physiol Biochem       Date:  2018-10-03

6.  Targeting MDM2 for Treatment of Adenoid Cystic Carcinoma.

Authors:  Kristy A Warner; Felipe Nör; Gerson A Acasigua; Manoela D Martins; Zhaocheng Zhang; Scott A McLean; Matthew E Spector; Douglas B Chepeha; Joseph Helman; Michael J Wick; Christopher A Moskaluk; Rogerio M Castilho; Alexander T Pearson; Shaomeng Wang; Jacques E Nör
Journal:  Clin Cancer Res       Date:  2016-03-02       Impact factor: 12.531

7.  Synergistic efficacy of combined EGFR and HDAC inhibitors overcomes tolerance to EGFR monotherapy in salivary mucoepidermoid carcinoma.

Authors:  Kshitij Parag-Sharma; Jason Tasoulas; Adele M Musicant; Carlos H Viesi do Nascimento-Filho; Zhichuan Zhu; Chloe Twomey; Pengda Liu; Rogerio M Castilho; Antonio L Amelio
Journal:  Oral Oncol       Date:  2021-02-11       Impact factor: 5.337

8.  Altered presence of extra cellular matrix components in murine skin cancer: Modulation by Azadirachta indica leaf extract.

Authors:  N A Chugh; A Koul
Journal:  J Tradit Complement Med       Date:  2020-03-29

9.  CRTC1/MAML2 directs a PGC-1α-IGF-1 circuit that confers vulnerability to PPARγ inhibition.

Authors:  Adele M Musicant; Kshitij Parag-Sharma; Weida Gong; Monideepa Sengupta; Arindam Chatterjee; Erin C Henry; Yi-Hsuan Tsai; Michele C Hayward; Siddharth Sheth; Renee Betancourt; Trevor G Hackman; Ricardo J Padilla; Joel S Parker; Jimena Giudice; Colin A Flaveny; David N Hayes; Antonio L Amelio
Journal:  Cell Rep       Date:  2021-02-23       Impact factor: 9.423

10.  Ductal activation of oncogenic KRAS alone induces sarcomatoid phenotype.

Authors:  Yong Fu; Zobeida Cruz-Monserrate; H Helen Lin; Yiyin Chung; Baoan Ji; Szu-Min Lin; Steven Vonderfecht; Craig D Logsdon; Chien-Feng Li; David K Ann
Journal:  Sci Rep       Date:  2015-08-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.